We serve Chemical Name:3-oxo-4-phenylquinoxaline-2-carboxylic acid CAS:860502-84-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-oxo-4-phenylquinoxaline-2-carboxylic acid
CAS.NO:860502-84-7
Synonyms:2-Quinoxalinecarboxylic acid, 3,4-dihydro-3-oxo-4-phenyl-;3-Oxo-4-phenyl-3,4-dihydro-chinoxalin-2-carbonsaeure;3-Oxo-4-phenyl-3,4-dihydro-2-quinoxalinecarboxylic acid;3-oxo-4-phenyl-3,4-dihydro-quinoxaline-2-carboxylic acid
Molecular Formula:C15H10N2O3
Molecular Weight:266.251
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:488.8±28.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.675
PSA:72.19000
Exact Mass:266.069153
LogP:1.72
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Quinoxalinecarboxylic acid, 3,4-dihydro-3-oxo-4-phenyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-oxo-4-phenyl-3,4-dihydro-quinoxaline-2-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Quinoxalinecarboxylic acid, 3,4-dihydro-3-oxo-4-phenyl- Use and application,2-Quinoxalinecarboxylic acid, 3,4-dihydro-3-oxo-4-phenyl- technical grade,usp/ep/jp grade.
Related News: BetterUp currently works with more than 370 organizations, of which more than 40 have European headquarters. New partners in the region include bp, which will be onboarding employees this month to support the mental fitness and well-being of the company’s teams. 6-(1H-pyrrol-1-yl)hexyl ((1S)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate manufacturers It has also been possible to prepare enzymes that can function effectively in organic solvents, thereby dramatically increasing the number of reactions possible. (3,4-Dimethyl-phenyl)-acetylchlorid suppliers CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells. diethyl 2-(((1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)amino)methylene)malonate vendor & factory.
